Fournier Gangrene
📧 Sign up to get email alerts when something new happens for Fournier Gangrene.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
The FATAL-NSTI study, sponsored by the University of Cagliari, is currently recruiting to identify factors associated with in-hospital morta…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Necrotizing Soft Tissue Infections
The document reports an ongoing clinical trial enrollment by invitation for necrotizing soft tissue infections, including Fournier gangrene,…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Anatomical Scale for the Prognosis of Fournier Syndrome. [Phase 3]
Phase 3 clinical trial update indicating completion of a study evaluating an anatomical scale for the prognosis of Fournier's gangrene. No r…
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections [Phase 3]
Phase III trial evaluating AB103 for necrotizing soft tissue infections completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections [NA]
Clinical trial update for daptomycin in severe necrotizing soft-tissue infections; completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-02-23Clinical Trial Update: Fournier's Gangrene and the Origin of the Infection as a Prognostic of Morbidity and Mortality, an Analysis of 121 Patients
A completed clinical trial analysis of 121 patients investigates whether the origin of infection in Fournier's gangrene serves as a prognost…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial [Phase 2]
A Phase 2 randomized controlled trial evaluating intravenous immunoglobulin for necrotizing soft-tissue infections has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Biomarkers in Patients With Flesh-eating Bacterial Infections
Completed trial investigating biomarkers in patients with flesh-eating bacterial infections to understand disease biology and identify poten…